WallStreetZenWallStreetZen

NASDAQ: LIXT
Lixte Biotechnology Holdings Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

LIXT earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$5.1M
Current Profit Margin
0%

LIXT Return on Equity

Current Company
-129.7%
Current Industry
-63.5%
Current Market
188%
LIXT's Return on Equity (-129.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when LIXT announces earnings.

LIXT Return on Assets

Current Company
-119.9%
Current Industry
2.9%
LIXT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LIXT Return on Capital Employed

Current Company
-126.94%
Current Industry
19.5%
LIXT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LIXT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LIXT$0.00-$5.07M-$5.09MN/AN/A
EFTR$0.00-$32.78M-$35.81M-100.00%N/A
KA$5.44M-$13.01M-$14.10M+13.89%N/A
TRVN$3.13M-$35.99M-$40.29M-11.43%N/A
PULM$7.30M-$12.65M-$14.12M+116.62%N/A
View Top Biotech Stocks

LIXT earnings dates

Next earnings date
May 8, 2024

Lixte Biotechnology Holdings Earnings & Revenue FAQ

What were LIXT's earnings last quarter?

On Invalid Date, Lixte Biotechnology Holdings (NASDAQ: LIXT) reported Q4 2023 earnings per share (EPS) of -$0.41, up 58.16% year over year. Total Lixte Biotechnology Holdings earnings for the quarter were -$1.03 million. In the same quarter last year, Lixte Biotechnology Holdings's earnings per share (EPS) was -$0.98.

If you're new to stock investing, here's how to buy Lixte Biotechnology Holdings stock.

What was LIXT's earnings growth in the past year?

As of Q2 2024, Lixte Biotechnology Holdings's earnings has grown year over year. Lixte Biotechnology Holdings's earnings in the past year totalled -$5.09 million.

What is LIXT's earnings date?

Lixte Biotechnology Holdings's earnings date is Invalid Date. Add LIXT to your watchlist to be reminded of LIXT's next earnings announcement.

What was LIXT's revenue last quarter?

On Invalid Date, Lixte Biotechnology Holdings (NASDAQ: LIXT) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Lixte Biotechnology Holdings's revenue was $0.00.

What was LIXT's revenue growth in the past year?

As of Q2 2024, Lixte Biotechnology Holdings's revenue has grown null year over year. Lixte Biotechnology Holdings's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.